Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors
Vilariño, N.; Bruna, J.; Kalofonou, F.; Anastopoulou, G.G.; Argyriou, A.A. Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors. Int. J. Mol. Sci. 2020, 21, 5774. https://doi.org/10.3390/ijms21165774
Vilariño N, Bruna J, Kalofonou F, Anastopoulou GG, Argyriou AA. Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. 2020; 21(16):5774. https://doi.org/10.3390/ijms21165774
Chicago/Turabian StyleVilariño, Noelia, Jordi Bruna, Foteini Kalofonou, Garifallia G. Anastopoulou, and Andreas A. Argyriou. 2020. "Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors" International Journal of Molecular Sciences 21, no. 16: 5774. https://doi.org/10.3390/ijms21165774